$350.00
| Packaging Type | Box |
| Brand | Lilly |
| Composition | Somatropin |
| Usage | To treat Growth Hormone Deficiency (GHD) |
| Also Gives | PCD Pharma Franchise |
| Availability | In Stock |
Somatropin (recombinant human growth hormone, rhGH) is a synthetic version of the hormone naturally produced by the pituitary gland. Humatrope Lilly 18 IU (6 mg) is a somatropin-based therapy developed by Eli Lilly and Company, designed for consistent and controlled dosing in medically supervised treatment plans. It is a prescription-only medication that requires qualified medical supervision.
Recombinant human growth hormone plays a key role in:
When natural hormone production is insufficient, somatropin therapy may be prescribed to restore normal physiological balance.
Somatropin therapies such as Humatrope Lilly 18 IU (6 mg) may be prescribed for:
Use is based on confirmed diagnosis and specialist evaluation.
Somatropin mimics the body’s natural growth hormone by:
These effects contribute to improved growth outcomes and overall physiological health.
Patients should follow healthcare provider instructions carefully.
Seek medical attention if severe or persistent symptoms occur.
Somatropin products, including Humatrope Lilly 18 IU (6 mg), are regulated prescription medications in many countries. Unauthorized use or distribution may be illegal.

















